Antares Pharma Stocktwits

Antares Pharma Stocktwits - Ais from the largest community of traders and investors. Its strategy is to identify new or existing approved drug formulations and apply its drug delivery technology to enhance the drug compounds.

Antares Pharma Atrs Reports Next Week What To Expect - October 28 2021 - Zackscom

Antares pharma announces oral presentation at the 22nd annual fall scientific meeting of smsna.

Antares pharma stocktwits. On average, they anticipate antares pharma's stock price to reach $6.63 in the next twelve months. It develops, manufactures, and commercialize novel therapeutic products using its drug delivery systems. Times, the chicago tribune, seeking alpha, zacks investment research, the motley fool, business insider, mashable.com, stocktwits, venture beat, the fly on the wall, and more.

Atrs) (the “company”), a specialty pharmaceutical company, today announced that an abstract on xyosted ®, a subcutaneous testosterone enanthate injection, was accepted as on oral presentation at the 22 nd annual fall scientific meeting of smsna. The company has a portfolio of proprietary and partnered commercial products with several product candidates in. ( atrs ), a specialty pharmaceutical company, today announced it will release its second quarter 2021 financial and operating results on thursday, august 5, 2021, before the market opens.

Antares pharma found using ticker (atrs) now have 6 analysts in total covering the stock. Earnings for antares pharma are expected to grow by 100.00% in the coming year, from $0.11 to $0.22 per share. Antares pharma, inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of pharmaceutical products and technologies that address unmet needs in targeted therapeutic areas.

Ampe amyris amrs analog devices adi anaplan plan anaptys bio anab anavex life sciences avxl andersons inc ande angiodynamics ango angion biomedica angn ani pharmaceuticals anip anika therapeut anik annaly capital management nly annexon annx ansys inc anss antares. Antares will host a conference call on thursday, august 5, 2021 at 8:30am et to discuss the results. The consensus rating is ‘strong_buy’.

You can unlock it all now. We have 9 different ratings for every stock to help you appreciate its future potential. Is a combination drug device company, which engages in the development and comm.

Antares pharma inc is a specialty pharmaceutical company. This suggests a possible upside of. Latest antares pharma (atrs) stock news, antares pharma, inc.

Do not follow this link! Antares pharma stock is also rising on this news because the newly approved device utilizes the company's quickshot technology. Shares of the companies are trading up 29% and 19%, respectively.

We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, profitability, risk and earnings. Antares pharma inc add to watchlists. The range between the high target price and low target price is between 8 and 4.5 with the average target price sitting at 6.42.

Their forecasts range from $5.50 to $7.00. Insider & institutional ownership 24.8% of asensus surgical shares are owned by. Amphastar pharmaceuticals amph amphenol corp a aph ampio pharmaceuticals inc.

Antares pharma inc • medical instruments/supplies fri 22 oct, close current 1 day ago 2 days ago 3 days ago 4 days ago 5 days ago 6 days ago 7 days ago 8 days ago 9 days ago 10 days ago 11 days ago 12 days ago 13 days ago 14 days ago 15 days ago 16 days ago 17 days ago 18 days ago 19 days ago 20 days ago 21 days ago 22 days ago 23 days ago 24. The company's products include otrexup, elestrin, gelnique, makena, and others.